Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

Despite significant advances in glioma diagnosis and treatment, overall outcomes remain
suboptimal. Exploring novel therapeutic avenues show promise in advancing the field …

Radionuclide-mediated diagnosis and therapy have emerged as effective and low-risk
approaches to treating breast cancer. Compared to traditional anatomic imaging techniques …

Theranostics refers to the combination of diagnostic biomarkers with therapeutic agents that
share a specific target expressed by diseased cells and tissues. Nuclear medicine is an …

Radioligand therapeutics (RLT) aim to selectively deliver radioisotopes to cancer tissues to
eradicate tumor cells while limiting the damage to surrounding tissues. The therapeutic …

The path of the development of nuclear medicine at the international level and that in Russia
is presented. Significant achievements in the development and establishment of nuclear …

The advantages of personalized medicine and modern technologies of targeted nuclear
medicine are presented. Examples of the most efficient theranostic pairs in the treatment of …

A radionuclide is a nuclide carrying excess nuclear energy that can emit either alpha
particles carrying high energy with a short range, beta particles carrying low energy with a …

Представлен путь развития ядерной медицины на международном и отечественном
уровнях. Представлены значимые достижения в развитии и становлении ядерно …

Targeted alpha therapy (TAT) combines an alpha emitting radioisotope with an appropriate
biological targeting molecule to selectively bind to cancer cells and deliver highly localised …